DD129997A5 - Verfahren zur herstellung neuer antibiotischer praeparate zur pharmazeutischen verwendung - Google Patents

Verfahren zur herstellung neuer antibiotischer praeparate zur pharmazeutischen verwendung

Info

Publication number
DD129997A5
DD129997A5 DD7600196699A DD19669976A DD129997A5 DD 129997 A5 DD129997 A5 DD 129997A5 DD 7600196699 A DD7600196699 A DD 7600196699A DD 19669976 A DD19669976 A DD 19669976A DD 129997 A5 DD129997 A5 DD 129997A5
Authority
DD
German Democratic Republic
Prior art keywords
preparates
pharmaceutical use
new antibiotic
preparing new
preparing
Prior art date
Application number
DD7600196699A
Other languages
German (de)
English (en)
Inventor
William Wellesley Armstrong
Saurabhkumar Jayavantrai Desai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD129997A5 publication Critical patent/DD129997A5/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
DD7600196699A 1976-01-02 1976-12-29 Verfahren zur herstellung neuer antibiotischer praeparate zur pharmazeutischen verwendung DD129997A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/646,295 US4018889A (en) 1976-01-02 1976-01-02 Oxytetracycline compositions
CA268,177A CA1075603A (en) 1976-01-02 1976-12-17 Stable solutions of doxycycline in aqueous 2-pyrrolidone
KR7700012A KR810000900B1 (ko) 1976-01-02 1977-01-06 항생물질 조성제의 안정화 방법

Publications (1)

Publication Number Publication Date
DD129997A5 true DD129997A5 (de) 1978-03-01

Family

ID=27164830

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7600196699A DD129997A5 (de) 1976-01-02 1976-12-29 Verfahren zur herstellung neuer antibiotischer praeparate zur pharmazeutischen verwendung

Country Status (29)

Country Link
US (3) US4018889A (cs)
JP (1) JPS5290616A (cs)
KR (1) KR810000900B1 (cs)
AR (1) AR209242A1 (cs)
AT (1) AT345977B (cs)
BE (1) BE849885A (cs)
BG (1) BG36493A3 (cs)
CA (2) CA1075603A (cs)
CH (1) CH616080A5 (cs)
CS (1) CS205030B2 (cs)
DD (1) DD129997A5 (cs)
DE (1) DE2659152C2 (cs)
DK (1) DK145753C (cs)
EG (1) EG12291A (cs)
FI (1) FI56116C (cs)
FR (1) FR2336937A1 (cs)
GB (1) GB1520197A (cs)
GR (1) GR65305B (cs)
HK (1) HK30181A (cs)
IE (1) IE44767B1 (cs)
IN (1) IN145845B (cs)
KE (1) KE3166A (cs)
LU (1) LU76493A1 (cs)
NL (1) NL166620C (cs)
OA (1) OA05524A (cs)
PT (1) PT66017B (cs)
SE (1) SE435997B (cs)
SU (1) SU1309901A3 (cs)
ZA (1) ZA767689B (cs)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126680A (en) * 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
EP0009559B1 (de) * 1978-08-01 1982-08-25 Ciba-Geigy Ag Stabile flüssige Arzneimittelformulierung, ihre Herstellung und Verwendung
DE2965917D1 (en) * 1978-12-08 1983-08-25 Beecham Group Plc A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
DE3064250D1 (en) * 1979-07-02 1983-08-25 Pfizer Long acting sulfonamide injectable compositions
ATE3750T1 (de) * 1979-07-05 1983-06-15 Pfizer Inc. Sulfonamidloesungen.
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
NL178941C (nl) * 1982-06-15 1986-06-16 Aesculaap Bv Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
US4769232A (en) * 1984-03-22 1988-09-06 Pfizer Inc. Parenteral formulations of indolmycin
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
FR2608044B1 (fr) * 1986-12-10 1992-09-11 Sogeval Composition antibiotique aqueuse a usage veterinaire
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
EA012203B1 (ru) 1999-09-14 2009-08-28 Трастис Оф Тафтс Коллидж Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
EP1255565A1 (de) * 2000-01-13 2002-11-13 MERCK PATENT GmbH Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
EP1263442A1 (en) * 2000-01-24 2002-12-11 Trustees Of Tufts College TETRACYCLINE COMPOUNDS FOR TREATMENT OF i CRYPTOSPORIDIUM PARVUM /i RELATED DISORDERS
CN1430600A (zh) * 2000-03-31 2003-07-16 塔夫茨大学信托人 7－和9－氨基甲酸酯、脲、硫脲、硫代氨基甲酸酯,和杂芳基－氨基取代的四环素化合物
US6642270B2 (en) * 2000-05-15 2003-11-04 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
WO2001098236A2 (en) * 2000-06-16 2001-12-27 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
AU7164201A (en) 2000-07-07 2002-01-21 Tufts College 7-substituted tetracycline compounds
KR20030017609A (ko) 2000-07-07 2003-03-03 트러스티즈 오브 터프츠 칼리지 13-치환된 메타사이클린 화합물
EP1303479B1 (en) 2000-07-07 2011-04-06 Trustees Of Tufts College 7-, 8- and 9-substituted tetracycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
DK1679305T3 (da) 2000-07-07 2012-05-29 Tufts College 9-substituerede minocyclinforbindelser
RU2178698C1 (ru) * 2000-11-28 2002-01-27 Закрытое Акционерное Общество "Нита-Фарм" Способ получения композиции магниевого комплекса окситетрациклина пролонгированного действия
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP1241160A1 (en) * 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
WO2002072532A1 (en) 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7, 9-substituted tetracycline compounds
WO2002072506A2 (en) * 2001-03-13 2002-09-19 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
CA2440757A1 (en) 2001-03-14 2002-09-19 Michael Draper Substituted tetracycline compounds as synergistic antifungal agents
CA2457234A1 (en) 2001-03-14 2002-09-19 Mark L. Nelson Substituted tetracycline compounds as antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP2186793A1 (en) 2001-04-24 2010-05-19 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
US7056902B2 (en) 2002-01-08 2006-06-06 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
KR101014918B1 (ko) 2002-03-08 2011-02-15 파라테크 파마슈티컬스, 인크. 아미노-메틸 치환된 테트라시클린 화합물
KR101083498B1 (ko) 2002-03-21 2011-11-16 파라테크 파마슈티컬스, 인크. 치환된 테트라시클린 화합물
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
CN1700922A (zh) 2002-07-12 2005-11-23 帕拉特克药品公司 3、10或12a位取代的四环素化合物
CA2502464A1 (en) 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP1585555A2 (en) * 2002-12-27 2005-10-19 Angiotech International Ag Compositions and methods of using collagen and mmpi
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
KR101228706B1 (ko) 2003-07-09 2013-02-01 파라테크 파마슈티컬스, 인크. 치환된 테트라시클린 화합물
AU2004259661B2 (en) 2003-07-09 2011-11-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
WO2005011707A1 (en) * 2003-07-25 2005-02-10 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
CA2553510C (en) * 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
AU2005299569B2 (en) 2004-10-25 2012-06-07 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
EP2301912A3 (en) 2004-10-25 2012-07-11 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
NZ556582A (en) * 2005-01-21 2010-12-24 Warner Chilcott Co Llc A tetracycline metal complex in a solid dosage form
US8088755B2 (en) * 2005-02-04 2012-01-03 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
WO2007014154A2 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
AU2007208214B2 (en) * 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
EP2007713A2 (en) * 2006-04-17 2008-12-31 Teva Pharmaceutical Industries Ltd Isolation of tetracycline derivatives
EP2016045B1 (en) * 2006-04-24 2014-10-29 Teva Pharmaceutical Industries, Ltd. A tigecycline crystalline form and processes for its preparation
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
WO2007133798A2 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
WO2008079363A2 (en) 2006-12-21 2008-07-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
EP2452935A3 (en) 2006-12-21 2012-08-29 Paratek Pharmaceuticals, Inc. Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
JP2010523684A (ja) * 2007-04-12 2010-07-15 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物を用いる、脊髄筋委縮症を治療するための方法
EP2216323A3 (en) * 2007-04-27 2010-12-29 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
CA2693376A1 (en) 2007-07-06 2009-01-15 Paratek Pharmaceuticals, Inc. Methods for synthesizing substituted tetracycline compounds
MX2010009693A (es) 2008-03-05 2010-12-20 Paratek Pharm Innc Compuestos de monociclina y metodos de uso de la misma.
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
EP2276342A4 (en) * 2008-04-14 2012-02-22 Paratek Pharm Innc SUBSTITUTED TETRACYCLIN COMPOUNDS
TW202021946A (zh) 2008-05-19 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
MX2011002780A (es) * 2008-09-19 2011-04-27 Paratek Pharm Innc Compuestos de tetraciclina para el tratamiento de artritis reumatoide y metodos relacionados de tratamiento.
EP2990051B1 (en) 2009-04-10 2016-10-26 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (mmp-1)
HUE033161T2 (en) 2010-05-12 2017-11-28 Rempex Pharmaceuticals Inc Tetracycline compositions
HUE044536T2 (hu) 2011-05-12 2019-10-28 Paratek Pharm Innc A (4S,4aS,5aR,12aS)-4-dimetilamino-3,10,12,12a-tetrahidroxi-7-[(metoxi(metil)amino)-metil]- 1,11-dioxo-1,4,4a,5,5a,6,11,12a-oktahidro-naftacén-2-karbonsav amid és alkalmazási módszerei
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2015021387A2 (en) * 2013-08-09 2015-02-12 Britt George N Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
CN103536530A (zh) * 2013-10-30 2014-01-29 王玉万 盐酸多西环素长效注射剂及制备方法
MX2017012062A (es) 2015-03-23 2018-06-18 Biopharmx Inc Composicion farmaceutica de tetraciclina para uso dermatologico.
CN104721133B (zh) * 2015-04-14 2018-05-18 四川美嘉龙生物科技有限公司 一种土霉素制剂及制备方法
SG10201913599RA (en) 2016-11-01 2020-02-27 Paratek Pharm Innc 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (cabp)
CA3070663A1 (en) 2017-07-21 2019-01-24 Almirall, Llc Treatment of non-inflammatory lesions
TWI841543B (zh) 2017-11-28 2024-05-11 德商Ｃ 樂克塔股份有限公司 生產海藻糖之方法
US11426351B2 (en) 2019-12-26 2022-08-30 Sunstar Inc. Process for producing a pharmaceutical composition containing micro particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB805026A (en) * 1956-03-02 1958-11-26 Konink Nl Gisten Spiritusfabri Process for enhancing the solubility of medicines in water
GB802111A (en) * 1956-09-25 1958-10-01 Irwin Irville Lubowe Improved non-toxic pesticidal compositions
US2990331A (en) * 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
DE1091287B (de) * 1957-04-09 1960-10-20 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung stabiler, waessriger Loesungen von Tyrothricin und Subtilin
US2980584A (en) * 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2987437A (en) * 1958-03-06 1961-06-06 Gen Aniline & Film Corp Nematocidal composition
US3062717A (en) * 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3957972A (en) * 1966-05-31 1976-05-18 Koninklijke Nederlandsche Gist-En Spiritusfabriek N.V. Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
NL6607516A (cs) * 1966-05-31 1967-12-01
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
GB1508601A (en) * 1974-01-19 1978-04-26 Norbrook Labor Ltd Oxytetracycline solution
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
GB1538903A (en) 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent

Also Published As

Publication number Publication date
DK584676A (da) 1977-07-03
KE3166A (en) 1981-11-06
AR209242A1 (es) 1977-03-31
US4086332A (en) 1978-04-25
OA05524A (fr) 1981-04-30
NL166620C (nl) 1981-09-15
FI763716A7 (cs) 1977-07-03
NL7614470A (nl) 1977-07-05
IE44767L (en) 1977-07-02
BE849885A (fr) 1977-06-28
SU1309901A3 (ru) 1987-05-07
IE44767B1 (en) 1982-03-24
KR810000900B1 (ko) 1981-08-19
CA1075603A (en) 1980-04-15
US4081528A (en) 1978-03-28
FI56116C (fi) 1979-12-10
AU2057176A (en) 1978-09-28
CH616080A5 (cs) 1980-03-14
SE435997B (sv) 1984-11-05
LU76493A1 (cs) 1977-07-05
FR2336937B1 (cs) 1980-06-27
IN145845B (cs) 1979-01-06
SE7613959L (sv) 1977-07-03
US4018889A (en) 1977-04-19
ZA767689B (en) 1977-12-28
ATA971776A (de) 1978-02-15
GR65305B (en) 1980-08-01
PT66017B (en) 1978-06-19
AT345977B (de) 1978-10-10
DK145753C (da) 1983-08-08
BG36493A3 (en) 1984-11-15
DE2659152C2 (de) 1984-04-05
EG12291A (en) 1978-09-30
GB1520197A (en) 1978-08-02
HK30181A (en) 1981-07-10
DE2659152A1 (de) 1977-07-14
FR2336937A1 (fr) 1977-07-29
JPS5290616A (en) 1977-07-30
CS205030B2 (en) 1981-04-30
FI56116B (fi) 1979-08-31
DK145753B (da) 1983-02-21
JPS565368B2 (cs) 1981-02-04
CA1072012A (en) 1980-02-19
PT66017A (en) 1977-01-01
NL166620B (nl) 1981-04-15

Similar Documents

Publication Publication Date Title
DD129997A5 (de) Verfahren zur herstellung neuer antibiotischer praeparate zur pharmazeutischen verwendung
DD134642A5 (de) Verfahren zur herstellung neuer 1-aryloxy-2-hydroxy-3-alkylenaminopropane
DD136738A5 (de) Verfahren zur herstellung neuer polypeptide
DD137107A5 (de) Verfahren zur herstellung von spiro-hydantoinderivaten
AT342770B (de) Verfahren zur herstellung neuer erythromycinderivate
AT359217B (de) Verfahren zur herstellung neuer peptid-derivate
DD132869A5 (de) Verfahren zur herstellung neuer aminothiazolylazetamido-derivate
AT364095B (de) Verfahren zur herstellung neuer peptidderivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
DD137710A5 (de) Verfahren zur herstellung neuer 1-acyl-2-cyanaziridine
ATA60577A (de) Verfahren zur herstellung neuer polypeptidderivate
DD128133A5 (de) Verfahren zur herstellung neuer piperazinderivate
DD133949A5 (de) Verfahren zur herstellung neuer benzopyranderivate
DD137584A5 (de) Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten
PT71741B (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
DD131028A5 (de) Verfahren zur herstellung von pregnan-derivaten
DD134351A5 (de) Verfahren zur herstellung neuer pyridobenzodiazepinonen
DD131558A5 (de) Verfahren zur herstellung neuer indolizinderivate
DD136837A5 (de) Verfahren zur herstellung pharmazeutisch wirksamer pteridin-verbindungen
DD135390A5 (de) Verfahren zur herstellung neuer aryl-hexafuranoside
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
AT351673B (de) Verfahren zur herstellung neuer antibiotika
AT373868B (de) Verfahren zur herstellung neuer macrolid-antibiotika
DD138774A5 (de) Verfahren zur herstellung neuer piperazinopyrrolobenzodiazepinen
DD128270A5 (de) Verfahren zur herstellung neuer azofarbstoffe